Adarsh Ravishankar

Dermatology

1701 Divisadero St
Fl 4
San Francisco, CA 94115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Anifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus.

Anifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 28, 2026

Histiocytoid Sweet syndrome-like presentation of mature plasmacytoid dendritic cell proliferation.

Histiocytoid Sweet syndrome-like presentation of mature plasmacytoid dendritic cell proliferation.

Journal: Dermatology online journal

Published: June 17, 2025

Evaluation of the neutrophil-to-lymphocyte ratio as a predictor for second keratinocyte carcinomas.

Evaluation of the neutrophil-to-lymphocyte ratio as a predictor for second keratinocyte carcinomas.

Journal: Archives of dermatological research

Published: July 24, 2024

Demonstration of Convolutional Neural Networks to Determine Patch Test Reactivity.

Demonstration of Convolutional Neural Networks to Determine Patch Test Reactivity.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: September 12, 2023

Validation of a Proprietary Deterioration Index Model and Performance in Hospitalized Adults.

Validation of a Proprietary Deterioration Index Model and Performance in Hospitalized Adults.

Journal: JAMA network open

Published: July 24, 2023

Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro.

Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro.

Journal: iScience

Published: October 03, 2022

Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.

Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.

Journal: Rheumatology (Oxford, England)

Published: June 21, 2022

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM.

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM.

Journal: Arthritis research & therapy

Published: March 12, 2022

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM.

Journal: Arthritis research & therapy

Published: July 20, 2021

Trends in Patch Testing in the Medicare Part B Fee-for-Service Population.

Trends in Patch Testing in the Medicare Part B Fee-for-Service Population.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: June 11, 2021

Identification of Similarities Between Skin Lesions in Patients With Antisynthetase Syndrome and Skin Lesions in Patients With Dermatomyositis by Highly Multiplexed Imaging Mass Cytometry.

Identification of Similarities Between Skin Lesions in Patients With Antisynthetase Syndrome and Skin Lesions in Patients With Dermatomyositis by Highly Multiplexed Imaging Mass Cytometry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 25, 2021

Environmental triggers of dermatomyositis: a narrative review.

Environmental triggers of dermatomyositis: a narrative review.

Journal: Annals of translational medicine

Published: April 12, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026